Medifast Inc Stock Analysis

MED Stock  USD 32.44  0.03  0.09%   
MEDIFAST INC is undervalued with Real Value of 43.3 and Target Price of 81.0. The main objective of MEDIFAST INC stock analysis is to determine its intrinsic value, which is an estimate of what MEDIFAST INC is worth, separate from its market price. There are two main types of MEDIFAST INC's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect MEDIFAST INC's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of MEDIFAST INC's stock to identify patterns and trends that may indicate its future price movements.
The MEDIFAST INC stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. MEDIFAST INC is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. MEDIFAST Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and MEDIFAST INC's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.

MEDIFAST Stock Analysis Notes

About 97.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.7. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. MEDIFAST INC has Price/Earnings To Growth (PEG) ratio of 1.95. The entity recorded earning per share (EPS) of 9.1. The firm last dividend was issued on the 18th of September 2023. MEDIFAST INC had 1:20 split on the February 14, 2011. Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company was founded in 1980 and is headquartered in Baltimore, Maryland. Medifast operates under Personal Services classification in the United States and is traded on New York Stock Exchange. It employs 984 people. To find out more about MEDIFAST INC contact Michael MacDonald at 410 581 8042 or learn more at https://medifastinc.com.

MEDIFAST INC Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. MEDIFAST INC's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding MEDIFAST INC or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
MEDIFAST INC generated a negative expected return over the last 90 days
MEDIFAST INC has high historical volatility and very poor performance
Over 97.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: Q4 Earnings Highlights Este Lauder Vs The Rest Of The Personal Care Stocks

MEDIFAST INC Upcoming and Recent Events

Earnings reports are used by MEDIFAST INC to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to MEDIFAST INC previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
20th of February 2024
Upcoming Quarterly Report
View
6th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

MEDIFAST Largest EPS Surprises

Earnings surprises can significantly impact MEDIFAST INC's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2009-03-12
2008-12-310.080.07-0.0112 
2007-11-08
2007-09-300.080.07-0.0112 
2005-11-09
2005-09-300.040.050.0125 
View All Earnings Estimates

MEDIFAST INC Thematic Classifications

In addition to having MEDIFAST INC stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Food Products Idea
Food Products
USA Equities from Food Products industry as classified by Fama & French

MEDIFAST Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as MEDIFAST INC is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MEDIFAST INC backward and forwards among themselves. MEDIFAST INC's institutional investor refers to the entity that pools money to purchase MEDIFAST INC's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Bank Of New York Mellon Corp2023-12-31
201.1 K
Charles Schwab Investment Management Inc2023-12-31
186.2 K
Hotchkis & Wiley Capital Management Llc2023-12-31
167.3 K
American Century Companies Inc2023-12-31
139.9 K
Jacobs Levy Equity Management, Inc.2023-09-30
129.7 K
Northern Trust Corp2023-12-31
125.5 K
Aqr Capital Management Llc2023-12-31
110.4 K
Ubs Group Ag2023-12-31
92 K
Ameriprise Financial Inc2023-12-31
91.3 K
Blackrock Inc2023-12-31
1.8 M
Vanguard Group Inc2023-12-31
1.7 M
Note, although MEDIFAST INC's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

MEDIFAST Market Capitalization

The company currently falls under 'Small-Cap' category with a total capitalization of 353.78 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MEDIFAST INC's market, we take the total number of its shares issued and multiply it by MEDIFAST INC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

MEDIFAST Profitablity

MEDIFAST INC's profitability indicators refer to fundamental financial ratios that showcase MEDIFAST INC's ability to generate income relative to its revenue or operating costs. If, let's say, MEDIFAST INC is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, MEDIFAST INC's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of MEDIFAST INC's profitability requires more research than a typical breakdown of MEDIFAST INC's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 0.09 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.05 %, which entails that for every 100 dollars of revenue, it generated $0.05 of operating income.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.32  0.34 
Return On Capital Employed 0.58  0.61 
Return On Assets 0.32  0.34 
Return On Equity 0.49  0.84 

Management Efficiency

MEDIFAST INC has Return on Asset of 0.2524 % which means that on every $100 spent on assets, it made $0.2524 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.5577 %, implying that it generated $0.5577 on every 100 dollars invested. MEDIFAST INC's management efficiency ratios could be used to measure how well MEDIFAST INC manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.34. The current year's Return On Capital Employed is expected to grow to 0.61. At present, MEDIFAST INC's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 15.4 M, whereas Net Tangible Assets are forecasted to decline to about 125 M.
Last ReportedProjected for Next Year
Book Value Per Share 18.51  19.44 
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share 18.51  19.44 
Enterprise Value Over EBITDA 4.73  4.49 
Price Book Value Ratio 3.63  4.14 
Enterprise Value Multiple 4.73  4.49 
Price Fair Value 3.63  4.14 
Enterprise Value397.2 M417.1 M
The analysis of MEDIFAST INC's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze MEDIFAST INC's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of MEDIFAST Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield
0.207
Forward Dividend Yield
0.207
Forward Dividend Rate
6.6
Beta
1.147

Technical Drivers

As of the 19th of April, MEDIFAST INC secures the mean deviation of 2.46, and Risk Adjusted Performance of (0.13). Compared to fundamental indicators, the technical analysis model lets you check possible technical drivers of MEDIFAST INC, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to analyze and collect data for thirteen technical drivers for MEDIFAST INC, which can be compared to its peers in the industry. Please verify MEDIFAST INC variance, as well as the relationship between the maximum drawdown and skewness to decide if MEDIFAST INC is priced fairly, providing market reflects its recent price of 32.44 per share. Given that MEDIFAST INC has information ratio of (0.24), we recommend you to check MEDIFAST INC's last-minute market performance to make sure the company can sustain itself in the future.

MEDIFAST INC Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. MEDIFAST INC middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for MEDIFAST INC. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

MEDIFAST INC Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific MEDIFAST INC insiders, such as employees or executives, is commonly permitted as long as it does not rely on MEDIFAST INC's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases MEDIFAST INC insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

MEDIFAST INC Predictive Daily Indicators

MEDIFAST INC intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of MEDIFAST INC stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

MEDIFAST INC Corporate Filings

F4
19th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
15th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
12th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
10K
20th of February 2024
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify
F4
16th of February 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13A
13th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
13A
22nd of January 2024
An amended filing to the original Schedule 13G
ViewVerify
8K
13th of December 2023
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

MEDIFAST INC Forecast Models

MEDIFAST INC's time-series forecasting models are one of many MEDIFAST INC's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary MEDIFAST INC's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About MEDIFAST Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how MEDIFAST INC prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling MEDIFAST shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as MEDIFAST INC. By using and applying MEDIFAST Stock analysis, traders can create a robust methodology for identifying MEDIFAST entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.12  0.13 
Operating Profit Margin 0.12  0.12 
Net Profit Margin 0.09  0.1 
Gross Profit Margin 0.72  0.54 

Current MEDIFAST Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. MEDIFAST analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. MEDIFAST analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
81.0Hold2Odds
MEDIFAST INC current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most MEDIFAST analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand MEDIFAST stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of MEDIFAST INC, talking to its executives and customers, or listening to MEDIFAST conference calls.
MEDIFAST Analyst Advice Details

MEDIFAST Stock Analysis Indicators

MEDIFAST INC stock analysis indicators help investors evaluate how MEDIFAST INC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading MEDIFAST INC shares will generate the highest return on investment. By understating and applying MEDIFAST INC stock analysis, traders can identify MEDIFAST INC position entry and exit signals to maximize returns.
Begin Period Cash Flow87.7 M
Common Stock Shares Outstanding10.9 M
Total Stockholder Equity201.5 M
Tax Provision31.5 M
Quarterly Earnings Growth Y O Y-0.773
Property Plant And Equipment Net67.1 M
Cash And Short Term Investments150 M
Cash94.4 M
Accounts Payable39.2 M
Net Debt-72.4 M
50 Day M A39.7006
Total Current Liabilities92.3 M
Other Operating Expenses945.7 M
Non Current Assets Total85.9 M
Non Currrent Assets Other14.7 M
Stock Based Compensation8.2 M
When determining whether MEDIFAST INC is a strong investment it is important to analyze MEDIFAST INC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MEDIFAST INC's future performance. For an informed investment choice regarding MEDIFAST Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.
Note that the MEDIFAST INC information on this page should be used as a complementary analysis to other MEDIFAST INC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for MEDIFAST Stock analysis

When running MEDIFAST INC's price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Is MEDIFAST INC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.77)
Dividend Share
4.95
Earnings Share
9.1
Revenue Per Share
98.498
Quarterly Revenue Growth
(0.43)
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.